IP Library Granted Patent US 10,261,092
Granted Patent B2
US 10,261,092 · App. 14/696,904 · Granted Apr 16, 2019

Cross-reactive determinants and methods for their identification

Inventors: Thomas Plocher (Larchwood, IA); Manuel Campos (Alberta, CA); Richard Harland (Mississauga, CA); Todd Johnson (Larchwood, IA); Trent Harbison (Larchwood, IA); Dan Keil (Spring Hill, KS)
Assignee: Elanco Tiergesundheit AG
G01N33/6854A61K39/102G01N33/5052G01N33/6878A61K2039/552G01N2333/285
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,261,092
App. No.
14/696,904
Granted
Apr 16, 2019
Kind
B2
Abstract

Compositions and methods for determining immunologically cross-reactive molecules comprising a cross-reactive antigenic determinant are provided, in particular for determining proteins comprising cross-reactive antigenic determinants, in particular for determining proteins that are cross-reactive based on serological screens using sequential immunological challenges to an animal, including determining cross-reactive H. parasuis proteins. Also provided are compositions, vaccines, and kits using the molecules for diagnostics and methods for preventing or treating a disease, disorder, condition, or symptoms thereof associated with infectious agents, in particular infectious microorganisms, in particular for preventing or treating a disease, disorder, condition, or symptom thereof associated with H. parasuis infection.

Claims (22)

1. A method for indicating presence of a cross-reactive antigenic determinant on two or more molecules, the method comprising the steps of:

Obtaining at least one antibody from an animal exposed to a first immunological challenge comprising a first antigenic determinant followed by a second immunological challenge comprising a second antigenic determinant,

wherein the first antigenic determinant is expressed by a first H. parasuis microorganism and the second antigenic determinant is expressed by a second H. parasuis microorganism, and

wherein the first and second H. parasuis microorganisms are characterized as being different serotypes;

contacting the at least one antibody with a first antigenic determinant and detecting binding; and

contacting the at least one antibody with a second antigenic determinant and detecting binding,

wherein binding of the at least one antibody to both the first and the second antigenic determinant is indicative of antibody cross-reactivity between antigenic determinants of two different H. parasuis serotypes.

2. The method of claim 1 , wherein the first H. parasuis microorganism is serotype 5, and wherein the second H. parasuis microorganism is serotype 13.

3. The method of claim 1 , wherein at least one of the first and the second antigenic determinants is present in a heme-binding protein.

4. The method of claim 1 , wherein the first and the second antigenic determinants comprise an amino acid sequence selected from the group consisting of:

(SEQ ID NO: 1)

ELANAI;

(SEQ ID NO: 2)

TVLAEKQEII;

(SEQ ID NO: 3)

APAKGSTIEAGIAYPIST

(SEQ ID NO: 4)

MKNLISI;

and

(SEQ ID NO: 5)

SPSDKTFKISAIPDYNAAEMT.

5. The method of claim 1 , wherein the animal is a porcine.

Assignments (1)
CHANGE OF NAME Recorded Aug 23, 2017
From: NOVARTIS TIERGESUNDHEIT AG
To: ELANCO TIERGESUNDHEIT AG
Reel/Frame 043363/0007 →
Continuity (3)
Division 12934654
Provisional Application 61040260 · Mar 28, 2008
Related Publication 20150293118A1 · Oct 15, 2015